Counteracting age-related VEGF signaling insufficiency promotes healthy aging and extends life span
Author(s) -
Myriam Grunewald,
Saran Kumar,
Husni Sharife,
E. Volinsky,
Alex GilelesHillel,
Tamar Licht,
Anna Permyakova,
Liad Hinden,
Shahar Azar,
Yasmin Friedmann,
P. Kupetz,
R. Tzuberi,
Andrey Anisimov,
Kari Alitalo,
M. J. Horwitz,
Shira Leebhoff,
Oleksiy-Zakhar Khoma,
Ruslan Hlushchuk,
Valentin Djonov,
Rinat Abramovitch,
Joseph Tam,
Eli Keshet
Publication year - 2021
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.abc8479
Subject(s) - sarcopenia , longevity , inflammation , medicine , senescence , osteoporosis , ageing , endocrinology , life span , vascular endothelial growth factor , physiology , vegf receptors , gerontology
More VEGF, more life—and health span Advanced aging is celebrated but its ill effects, deterioration at the cell, tissue, and organ levels, are not. Grunewaldet al . provide evidence for the vascular theory of aging, which reports that age-related decrease of vascular function is a driver of organismal aging at large (see the Perspective by Augustin and Kipnis). Vascular endothelial growth factor (VEGF) signaling insufficiency underlies this vascular insufficiency in aged mice. A modest compensatory increase in circulatory VEGF was sufficient to preserve a young-like vascular homeostasis, alleviate multiple adverse age-related processes, and ameliorate a host of age-associated pathologies in mice. —BAP
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom